Jessie Moore has been writing professionally for nearly two decades; for the past seven years, she's focused on writing, ghostwriting, and editing in the finance space. She is a Today Show and Publisher's Weekly-featured author who has written or ghostwritten 10+ books on a wide variety of topics, ranging from day trading to unicorns to plant care.
Grail is not publicly traded at this time. However, there are still ways for investors to gain indirect exposure to the company via its parent company and by exploring stocks in similar sectors.
We’ll talk about Grail’s parent company and other like-minded public companies below. If you choose to invest in any of them, consider one of our favorite brokers — eToro. (Use that link for a $10 bonus — terms and conditions apply.)
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Despite incredible medical advancements in recent decades, Cancer remains one of the most deadly diseases — representing one out of every six deaths.
American biotech company Grail is hoping to change that.
The company is looking to transform the medical landscape with its focus on early cancer detection. As an investor, you may be wondering how you can support that mission.
Luckily, there’s a way to get in on the action. So, without further ado, let’s learn how to buy Grail stock.
Grail: The Basics
Grail is the creator of an innovative pan-cancer screening test. Grail’s tests can purportedly detect the disease at earlier stages, improving the odds of combating it before it becomes fatal.
Naturally, should Grail successfully develop its tests for broad adoption, it would be a game-changer in the field of medicine and a substantial step forward in reducing human mortality.
Here are a few more details to know about Grail:
- The Menlo-Park, California-based company has received $2 billion in funding since its inception in 2016.
- Grail’s last funding round was on May 6, 2020.
- On September 21, 2020, it was announced that San Diego-based Illumina (NASDAQ: ILMN) acquired Grail for $8 billion.
- Grail’s Galleri test can detect a common signal shared by over 50 types of cancer and predict which tissue type or organ is likely affected, helping medical professionals during diagnoses.
- What makes Grail particularly unique is its focus on identifying cancer in patients who don’t yet show symptoms.
Can You Buy Grail Stock? Is Grail Publicly Traded?
Yes and no.
That’s probably not the answer you were looking for in your search for how to buy Grail stock, but let me explain!
While you can’t buy Grail stock directly, since 2020, you can purchase shares in Grail’s parent company, Illumina (NASDAQ: ILMN). Here’s the company chart, courtesy of TradingView:
How to Buy Grail as a Retail Investor
When people learn of Grail’s critical work, they often want to know how to buy Grail stock. After all, if it’s as good as it sounds, it could make for an excellent investment.
Likely, that’s why you’re here, to learn how to buy Grail stock.
Unfortunately, there is no Grail stock symbol, and you cannot buy Grail stock directly as a retail investor. You can, however, purchase shares in Grail’s publicly traded parent company, Illumina (NASDAQ: ILMN).
Worth noting: if you invest in Illumina, you’re investing in more than just Grail’s work. So be sure to do your due diligence and research the company as a whole.
Who Owns Grail?
Grail was founded in 2018 in Menlo Park, California. In September 2020, Grail was acquired by biotech company Illumina.
Does Sequoia Capital Own Grail?
Venture capital giant Sequoia Capital was one of the initial investors that backed Grail during a Series C funding round. The funding round, which also included other investors, like Hillhouse Capital Group, successfully raised $300 million.
How to Invest in Grail Stock as a Retail Investor
Note: This article does not provide investment advice. The stocks listed should not be taken as recommendations. Your investments are solely your decisions.
While you can’t buy Grail stock directly, you can easily purchase shares in Grail’s parent company, Illumina (NASDAQ: ILMN). Illumina is directly involved in the biotechnology space, so even though you’re buying shares in the umbrella company, the overarching sector remains the same.
Personalis (NASDAQ: PSNL) is another option to consider. Like Grail, this biotech firm is focused on providing early and insightful information about cancers that can empower medical professionals to treat patients more effectively.
How to Buy Grail Parent Company Illumina
Here are the steps on how to purchase shares in Illumina, the publicly traded parent company of Grail:
- Create or login to your brokerage account (if you don’t have one, we recommend eToro)
- Search for Illumina (NASDAQ: ILMN)
- Select how many shares you want to buy
- Place your order
- Monitor your trade
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Grail Stock Price Chart
Since Grail is not directly publicly traded, there is no Grail stock price chart. That said, Grail’s parent company Illumina is publicly traded, and therefore you can find an Illumina stock price chart like the following one from TradingView.
The bottom line? If you’re interested in Grail stock, consider looking into its parent company, Illumina.
FAQs:
How to buy Grail stock?
You can’t buy Grail stock directly, but you can easily purchase shares in Grail’s parent company, Illumina (NASDAQ: ILMN).
How much is Grail stock?
Since Grail is not individually publicly traded, there is no Grail stock price. However, Grail’s parent company Illumina (NASDAQ: ILMN), is publicly traded and, as of early June 2023, was trading at around $200 per share.
What is the Grail stock symbol?
Since Grail is not individually publicly traded, there is no Grail stock and no Grail stock symbol. However, Grail’s parent company Illumina (NASDAQ: ILMN), is publicly traded and uses the stock symbol $ILMN.
Who owns Grail stock?
Grail is wholly owned by Illumina (NASDAQ: ILMN), a publicly traded American biotechnology company based in Southern California.
Where to Invest $1,000 Right Now?
Did you know that stocks rated as "Buy" by the Top Analysts in WallStreetZen's database beat the S&P500 by 98.4% last year?
Our January report reveals the 3 "Strong Buy" stocks that market-beating analysts predict will outperform over the next year.
